A phase II trial of miltefosine in patients with cutaneous T-cell lymphoma.

Bulletin du cancer

Volumn 93, Issue 11, 2006, Pages

  Dumontet, Charles ^a   Thomas, Luc ^a   Bérard, Frédéric ^a   Gimonet, Jean François ^a   Coiffier, Bertrand ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; MILTEFOSINE; PHOSPHORYLCHOLINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CUTANEOUS T CELL LYMPHOMA; FEMALE; HUMAN; MALE; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; SKIN TUMOR;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; PHOSPHORYLCHOLINE; SKIN NEOPLASMS;

EID: 39049187901     PISSN: None     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Article

References (0)